| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |